Talking to Patients about the COVID-19 Vaccine
How you can engage and inform in a meaningful way
As COVID-19 vaccines are approved and distributed, providers will be a key part in its adoption and administration to the American public. Patients look to their healthcare professionals for medical guidance and assurance, and while much is still unknown, you can start laying the groundwork now for when the vaccines are available. As your partners in healthcare, we want to share some tips for effectively setting expectations and addressing questions from your patients.
Start COVID-19 Vaccine Conversations Early
Even before you are able to offer COVID-19 vaccinations, consider including the topic in your conversations with patients. This will give you the opportunity to set expectations about vaccine availability, including if/when you might recommend vaccination for them, and learn about any concerns they have.
Engage in Effective COVID-19 Vaccine Conversations
Effective engagement can occur during an in-person office visit, through messages on your patient portal, or at a telemedicine appointment. Patients trust in their providers to help guide healthcare decisions, and your strong vaccine recommendation is the most important part of the conversation.
Start with empathy and understanding.
- Acknowledge the disruption COVID-19 has caused in all our lives.
- Provide an opportunity to recognize common concerns that can be addressed by a vaccine.
Assume patients will want to be vaccinated but may not know when to expect it
- Consider providing the following general information to patients about the timeline for COVID-19 vaccines:
- COVID-19 vaccine doses are now widely available for anyone over the age of 5.
- The goal is for everyone to be able to easily get a COVID-19 vaccine and booster for those eligible as soon as possible.
- Encourage patients to continue taking steps to protect themselves from COVID-19 and let them know how you plan to share updates about vaccine availability.
Give your strong recommendation.
- Let your patients know if you plan to recommend COVID-19 vaccination for them.
- Share the importance of COVID-19 vaccines to protect patients’ health as well as the health of those around them.
- Talk about your personal plans to get a COVID-19 vaccine.
- Reassure your patients that the vaccine is safe.
Listen to and respond to questions.
- If a patient has concerns or questions, this doesn’t mean they won’t accept a COVID-19 vaccine. Sometimes patients want your answers to their questions.
- Your willingness to listen to their concerns will play a major role in building trust in you and your recommendation. Make it clear that you understand they have questions, and that you want to answer them, so they feel confident in choosing to get vaccinated.
- Seek to understand patient/caregiver concerns and provide information they need in a way they can understand it (see Q&A below).
Keep the conversation open.
- After answering their questions, let your patients know that you are open to continuing the conversation and answering any additional questions they may have.
- Encourage patients to take at least one action like:
- Scheduling another appointment.
- Reading any additional information you provide them about COVID-19 vaccination.
- Encourage others to get their COVID-19 vaccine when available.
- Continue to remind patients about the importance of getting a COVID-19 vaccine during future routine visits.
Answering Patient Questions about the Vaccine
Your patients will likely have a lot of questions about the vaccine, and as their healthcare provider, they will turn to you for answers.
Pharmacies, as well as mass vaccination sites, are generally the most convenient locations to individuals and they also have great expertise in administering vaccines. While many providers anticipate having the vaccine in their office later on, for now we recommend patients visit their local pharmacy or mass vaccination center. The website www.vaccinefinder.org can help them locate the closest location with current inventory.
The Food and Drug Administration (FDA) carefully reviews all safety data from clinical trials. It only authorizes emergency vaccine use when the expected vaccine benefits outweigh potential risks.
- The Advisory Committee on Immunization Practices (ACIP) reviews all safety data before recommending any COVID-19 vaccine for use.
- FDA and CDC will continue to monitor the safety of COVID-19 vaccines to make sure even very rare side effects are identified.
Explain the potential serious risk COVID-19 infection poses to them and their loved ones if they get the illness or spread it to others.
- Remind them of the potential for long-term health issues after recovery from COVID-19 disease, especially for those who have chronic conditions, are older, or have weakened immune systems.
- Explain that scientists are still learning more about the virus that causes COVID-19. And it is not known whether getting COVID-19 disease will protect everyone against getting it again, or, if it does, how long that protection might last. Therefore getting a vaccine is a safer choice.
- Some vaccines are more effective than the natural illness; it is not clear whether natural illness or vaccination will provide more effective immunity in this case.
- Early information indicates that COVID-19 vaccination may reduce the severity of illness, as well as the incidence of illness. As we learn more about the efficacy of the vaccine, we will also learn more about potential long-term protection it may bring.
- Describe how the vaccine was tested in large clinical trials and what is currently known about its safety and effectiveness.
- Be transparent that the vaccine is not a perfect fix. Patients will still need to practice other precautions like wearing a mask, social distancing, handwashing and other hygiene measures until public health officials say otherwise.
Two vaccines are needed to provide the best protection against COVID-19, as well as a booster for anyone age 12+ to prevent or reduce the severity of COVID-19 and its variants.
- The first vaccine primes the immune system and helps recognize the virus. The second vaccine strengthens the immune response. The booster gives further protection against new variants of the virus.
- The two doses are given a few weeks apart (e.g. 21 or 28 days depending on vaccine type). Explain the dosing options available in your office and advise the patient that they can set up an appointment before they leave to come back for a second dose.
- The booster is given at least 5 months after completing the primary COVID vaccine series.
- Provide members with a vaccination record card to ensure that they know when they received their first vaccine, what type of vaccine they received, and when they need to come back and receive their second vaccine.
- Direct them to their insurance health plan to set up non-emergency transportation, if applicable.
List the most common side effects from vaccination are and how severe they may be (e.g. fever, headache, body aches, cold symptoms). Emphasize that a fever could be a potential side effect and when to seek medical care.
- Symptoms will typically go away on their own within a week. Let them know when they should seek medical care if their symptoms don’t go away.
- Explain that the vaccine cannot give someone COVID-19 as the vaccine does not contain a live coronavirus.
- Explain that side effects are a sign that the immune system is effectively working.
No! The vaccine will be at no cost to patients. They will not have to pay for either dose of the COVID-19 vaccine.